Michael-Jubeli R et al. |
High-temperature gas chromatography-mass spectrometry for skin surface lipids profiling. |
2011 |
J. Lipid Res. |
pmid:20952798
|
Arias JL et al. |
Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. |
2011 |
ACS Nano |
pmid:21275408
|
van den Brand JM et al. |
Efficacy of vaccination with different combinations of MF59-adjuvanted and nonadjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza virus infection in ferrets. |
2011 |
J. Virol. |
pmid:21209108
|
Calabro S et al. |
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. |
2011 |
Vaccine |
pmid:21215831
|
Javelle E et al. |
Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine. |
2011 |
Vaccine |
pmid:21172376
|
Montagnani S et al. |
Autoimmune hemolytic anemia following MF59-adjuvanted influenza vaccine administration: a report of two cases. |
2011 |
Ann Pharmacother |
pmid:21189364
|
Esposito S et al. |
Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents. |
2011 |
Vaccine |
pmid:21199699
|
Lopez P et al. |
Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines: a phase II randomized, controlled trial of immunogenicity and safety in healthy adults. |
2011 |
J. Infect. Dis. |
pmid:21606530
|
Cen-Pacheco F et al. |
Cytotoxic oxasqualenoids from the red alga Laurencia viridis. |
2011 |
Eur J Med Chem |
pmid:21616566
|
Raouane M et al. |
Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma. |
2011 |
J. Med. Chem. |
pmid:21561161
|
Nowosielski M and Hoffmann M |
Do the substituent effects affect conformational freedom of squalene in hopene biosynthesis? |
2011 |
J Mol Model |
pmid:21562825
|
Hernández-GarcÃa I et al. |
[Adverse events after administration of A/H1N1 vaccine to patients]. |
2011 |
Med Clin (Barc) |
pmid:20199781
|
Bernstein DI |
Vaccines for cytomegalovirus. |
2011 |
Infect Disord Drug Targets |
pmid:22309618
|
Fox CB et al. |
Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions. |
2011 |
Pharm Dev Technol |
pmid:20550484
|
Fabbiani M et al. |
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients. |
2011 |
Vaccine |
pmid:21349364
|
Gill S et al. |
Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. |
2011 |
Cell Metab. |
pmid:21356516
|
Kaya K et al. |
Thraustochytrid Aurantiochytrium sp. 18W-13a accummulates high amounts of squalene. |
2011 |
Biosci. Biotechnol. Biochem. |
pmid:22056449
|
Cheong HJ et al. |
Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine. |
2011 |
Clin. Vaccine Immunol. |
pmid:21715575
|
Soto G et al. |
Acetoacetyl-CoA thiolase regulates the mevalonate pathway during abiotic stress adaptation. |
2011 |
J. Exp. Bot. |
pmid:21908473
|
Celia C et al. |
Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. |
2011 |
Expert Opin Drug Deliv |
pmid:22077480
|
Tsai TF |
MF59 adjuvanted seasonal and pandemic influenza vaccines. |
2011 |
Yakugaku Zasshi |
pmid:22129867
|
Puig-Barberà J et al. |
MF59â„¢-adjuvanted seasonal influenza vaccine in young children. |
2011 |
Expert Rev Vaccines |
pmid:22043952
|
Viganò A et al. |
Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial. |
2011 |
Clin. Vaccine Immunol. |
pmid:21795458
|
Huijskens E et al. |
Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population. |
2011 |
Clin. Vaccine Immunol. |
pmid:21795459
|
Pollard AJ and Hill AV |
Antibody repertoire: embracing diversity. |
2011 |
Sci Transl Med |
pmid:21795586
|
Okike IO et al. |
The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children. |
2011 |
Vaccine |
pmid:21742005
|
Achiraman S et al. |
Increased squalene concentrations in the clitoral gland during the estrous cycle in rats: an estrus-indicating scent mark? |
2011 |
Theriogenology |
pmid:21924481
|
Brito LA et al. |
An alternative renewable source of squalene for use in emulsion adjuvants. |
2011 |
Vaccine |
pmid:21723355
|
Wu J et al. |
Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice. |
2011 |
Arch. Virol. |
pmid:21110049
|
Packwood DM and Phillips LF |
A stochastic, local mode study of neon-liquid surface collision dynamics. |
2011 |
Phys Chem Chem Phys |
pmid:21042647
|
Andrews N et al. |
Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. |
2011 |
J. Infect. Dis. |
pmid:21148494
|
Kajaste-Rudnitski A et al. |
Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals. |
2011 |
AIDS |
pmid:21150561
|
Launay O et al. |
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. |
2011 |
J. Infect. Dis. |
pmid:21628666
|
Piccialli V et al. |
Isolation of a bis-iodurated tetra-THF as a trace product from the oxidation of squalene with RuOâ‚„ and its double ring expansion to a novel bis-THF-bis-THP compound. |
2011 |
Molecules |
pmid:21709619
|
Iannazzo S |
Pharmacoeconomic evaluation of the MF59--adjuvanted influenza vaccine in the elderly population in Italy. |
2011 |
J Prev Med Hyg |
pmid:21710816
|
Seubert A et al. |
Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21690334
|
Gao J et al. |
Laser-induced acoustic desorption/atmospheric pressure chemical ionization mass spectrometry. |
2011 |
J. Am. Soc. Mass Spectrom. |
pmid:21472571
|
Weschler CJ et al. |
Squalene and cholesterol in dust from danish homes and daycare centers. |
2011 |
Environ. Sci. Technol. |
pmid:21476540
|
Cauda V et al. |
"Liquid-phase calcination" of colloidal mesoporous silica nanoparticles in high-boiling solvents. |
2011 |
J. Am. Chem. Soc. |
pmid:21480591
|
Griffiths PD et al. |
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. |
2011 |
Lancet |
pmid:21481708
|
Liu CL et al. |
The direct observation of secondary radical chain chemistry in the heterogeneous reaction of chlorine atoms with submicron squalane droplets. |
2011 |
Phys Chem Chem Phys |
pmid:21455529
|
Inagaki YS et al. |
Investigation of the potential for triterpene synthesis in rice through genome mining and metabolic engineering. |
2011 |
New Phytol. |
pmid:21501172
|
Garcia-Sicilia J et al. |
Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. |
2011 |
Vaccine |
pmid:21504774
|
O'Hagan DT et al. |
MF59 adjuvant: the best insurance against influenza strain diversity. |
2011 |
Expert Rev Vaccines |
pmid:21506643
|
Esposito S et al. |
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children and adolescents with Williams or Cornelia De Lange syndrome. |
2011 |
Hum Vaccin |
pmid:21508673
|
AÄimoviÄ J et al. |
Circadian rhythm of cholesterol synthesis in mouse liver: a statistical analysis of the post-squalene metabolites in wild-type and Crem-knock-out mice. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21531203
|
Siedenburg G and Jendrossek D |
Squalene-hopene cyclases. |
2011 |
Appl. Environ. Microbiol. |
pmid:21531832
|
Tsai TF et al. |
Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy. |
2011 |
Scand. J. Infect. Dis. |
pmid:21534891
|
Esposito S et al. |
Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. |
2011 |
Pediatrics |
pmid:21464195
|
Esposito S et al. |
An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients. |
2011 |
Nephrol. Dial. Transplant. |
pmid:20974645
|